Skip to main content
Top
Published in: Current Heart Failure Reports 3/2010

01-09-2010

Rubbing Salt into Wounds: Hypertonic Saline to Assist with Volume Removal in Heart Failure

Authors: Mark Liszkowski, Anju Nohria

Published in: Current Heart Failure Reports | Issue 3/2010

Login to get access

Abstract

Traditionally accepted management strategies for patients with heart failure include sodium and fluid restriction, neurohormonal blockade, and the use of loop diuretics to achieve and maintain euvolemia. Despite continued advances in medical and device therapy, fluid management remains a significant problem in patients with the cardiorenal syndrome (manifested as diuretic resistance and worsening renal function with more aggressive attempts at volume removal). This article examines the counterintuitive use of hypertonic saline as a potential therapy to facilitate diuresis in patients with decompensated heart failure and diuretic resistance. Low-volume hypertonic saline administration offsets counterproductive neurohormonal upregulation, transiently improves hemodynamics, and promotes renal sodium excretion with accompanied net water loss and preservation of renal function. This “new” therapeutic tool should be explored further as an adjunct to current medical therapies in the management of patients with refractory volume overload.
Literature
1.
go back to reference Forman DE, Butler J, Wang Y, et al.: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:61–67.CrossRefPubMed Forman DE, Butler J, Wang Y, et al.: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:61–67.CrossRefPubMed
2.
go back to reference Cowie MR, Komajda M, Murray-Thomas T, et al.: Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006, 27:1216–1222.CrossRefPubMed Cowie MR, Komajda M, Murray-Thomas T, et al.: Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006, 27:1216–1222.CrossRefPubMed
3.
go back to reference Klein L, Massie BM, Leimberger JD, et al.: Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 2008, 1:25–33.CrossRefPubMed Klein L, Massie BM, Leimberger JD, et al.: Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 2008, 1:25–33.CrossRefPubMed
4.
go back to reference Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487–1491. (Published erratum appears in Circulation 2005, 111:2274.)CrossRefPubMed Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487–1491. (Published erratum appears in Circulation 2005, 111:2274.)CrossRefPubMed
5.
go back to reference Costanzo MR, Guglin ME, Saltzberg MT, et al.: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675–683. (Published erratum appears in J Am Coll Cardiol 2007, 49:1136.)CrossRefPubMed Costanzo MR, Guglin ME, Saltzberg MT, et al.: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675–683. (Published erratum appears in J Am Coll Cardiol 2007, 49:1136.)CrossRefPubMed
6.
go back to reference Konstam MA, Gheorghiade M, Burnett JC Jr, et al.: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297:1319–1331.CrossRefPubMed Konstam MA, Gheorghiade M, Burnett JC Jr, et al.: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297:1319–1331.CrossRefPubMed
7.
go back to reference Voors A: Effects of the adenosine A1-antagonist rolofylline on renal function in acute heart failure patients: results from the PROTECT study. J Am Coll Cardiol 2010, 55:E317.CrossRef Voors A: Effects of the adenosine A1-antagonist rolofylline on renal function in acute heart failure patients: results from the PROTECT study. J Am Coll Cardiol 2010, 55:E317.CrossRef
8.
go back to reference Cadnapaphornchai MA, Gurevich AK, Weinberger HD, Schrier RW: Pathophysiology of sodium and water retention in heart failure. Cardiology 2001, 96:122–131.CrossRefPubMed Cadnapaphornchai MA, Gurevich AK, Weinberger HD, Schrier RW: Pathophysiology of sodium and water retention in heart failure. Cardiology 2001, 96:122–131.CrossRefPubMed
9.
go back to reference Bell-Reuss E, Trevino DL, Gottschalk CW: Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 1976, 57:1104–1107.CrossRefPubMed Bell-Reuss E, Trevino DL, Gottschalk CW: Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 1976, 57:1104–1107.CrossRefPubMed
10.
go back to reference Blankstein R, Bakris GL: Renal hemodynamic changes in heart failure. Heart Fail Clin 2008, 4:411–423.CrossRefPubMed Blankstein R, Bakris GL: Renal hemodynamic changes in heart failure. Heart Fail Clin 2008, 4:411–423.CrossRefPubMed
11.
go back to reference Jessup M, Costanzo MR: The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol 2009, 53:597–599.CrossRefPubMed Jessup M, Costanzo MR: The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol 2009, 53:597–599.CrossRefPubMed
12.
go back to reference Kastner PR, Hall JE, Guyton AC: Renal hemodynamic responses to increased renal venous pressure: role of angiotensin II. Am J Physiol 1982, 243:F260–F264.PubMed Kastner PR, Hall JE, Guyton AC: Renal hemodynamic responses to increased renal venous pressure: role of angiotensin II. Am J Physiol 1982, 243:F260–F264.PubMed
13.
go back to reference Bayliss J, Norell M, Canepa-Anson R, et al.: Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987, 57:17–22.CrossRefPubMed Bayliss J, Norell M, Canepa-Anson R, et al.: Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987, 57:17–22.CrossRefPubMed
14.
go back to reference Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 2001, 96:132–143.CrossRefPubMed Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 2001, 96:132–143.CrossRefPubMed
15.
go back to reference Vandongen R: Intrarenal stimulation of renin secretion by frusemide in the isolated kidney of the rat. Br J Pharmacol 1977, 60:73–76.PubMed Vandongen R: Intrarenal stimulation of renin secretion by frusemide in the isolated kidney of the rat. Br J Pharmacol 1977, 60:73–76.PubMed
16.
go back to reference Kaissling B, Bachmann S, Kriz W: Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 1985, 248:F374–F381.PubMed Kaissling B, Bachmann S, Kriz W: Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 1985, 248:F374–F381.PubMed
17.
go back to reference Ellison DH, Velázquez H, Wright FS: Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 1989, 83:113–126.CrossRefPubMed Ellison DH, Velázquez H, Wright FS: Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 1989, 83:113–126.CrossRefPubMed
18.
go back to reference Alvelos M, Ferreira A, Bettencourt P, et al.: The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Fail 2004, 6:593–599.PubMed Alvelos M, Ferreira A, Bettencourt P, et al.: The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Fail 2004, 6:593–599.PubMed
19.
20.
go back to reference Paterna S, Di Pasquale P, Parrinello G, et al.: Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail 2000, 2:305–313.CrossRefPubMed Paterna S, Di Pasquale P, Parrinello G, et al.: Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail 2000, 2:305–313.CrossRefPubMed
21.
go back to reference •• Paterna S, Di Pasquale P, Parrinello G, et al.: Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 2005, 45:1997–2003. This article represents a double-blind randomized trial comparing the effects of small volumes of hypertonic saline plus high-dose diuretic therapy and a liberal dietary sodium intake to high-dose diuretic therapy alone with a restricted dietary sodium intake in patients with decompensated heart failure and diuretic resistance. This article also compares the effects of these two treatment strategies on B-type natriuretic peptide levels and on total body water content as measured by thoracic impedance. CrossRefPubMed •• Paterna S, Di Pasquale P, Parrinello G, et al.: Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 2005, 45:1997–2003. This article represents a double-blind randomized trial comparing the effects of small volumes of hypertonic saline plus high-dose diuretic therapy and a liberal dietary sodium intake to high-dose diuretic therapy alone with a restricted dietary sodium intake in patients with decompensated heart failure and diuretic resistance. This article also compares the effects of these two treatment strategies on B-type natriuretic peptide levels and on total body water content as measured by thoracic impedance. CrossRefPubMed
22.
go back to reference • Paterna S, Fasullo S, Di Pasquale P: High-dose torasemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure. Clin Drug Investig 2005, 25:165–173. This article compares the efficacy of small volumes of hypertonic saline in addition to furosemide versus torsemide in patients with decompensated heart failure and diuretic resistance. CrossRefPubMed • Paterna S, Fasullo S, Di Pasquale P: High-dose torasemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure. Clin Drug Investig 2005, 25:165–173. This article compares the efficacy of small volumes of hypertonic saline in addition to furosemide versus torsemide in patients with decompensated heart failure and diuretic resistance. CrossRefPubMed
23.
go back to reference Licata G, Di Pasquale P, Parrinello G, et al.: Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459–466.CrossRefPubMed Licata G, Di Pasquale P, Parrinello G, et al.: Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459–466.CrossRefPubMed
24.
go back to reference Hunt SA, Abraham WT, Chin MH, et al.: 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1–e90. (Published erratum appears in J Am Coll Cardiol 2009, 54:2464.)CrossRefPubMed Hunt SA, Abraham WT, Chin MH, et al.: 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1–e90. (Published erratum appears in J Am Coll Cardiol 2009, 54:2464.)CrossRefPubMed
25.
go back to reference Damgaard M, Gabrielsen A, Heer M, et al.: Effects of sodium intake on cardiovascular variables in humans during posture changes and ambulatory conditions. Am J Physiol Regul Integr Comp Physiol 2002, 283:R1404–R1411.PubMed Damgaard M, Gabrielsen A, Heer M, et al.: Effects of sodium intake on cardiovascular variables in humans during posture changes and ambulatory conditions. Am J Physiol Regul Integr Comp Physiol 2002, 283:R1404–R1411.PubMed
26.
go back to reference Damgaard M, Norsk P, Gustafsson F, et al.: Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1294–R1301.PubMed Damgaard M, Norsk P, Gustafsson F, et al.: Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1294–R1301.PubMed
27.
go back to reference Paterna S, Gaspare P, Fasullo S, et al.: Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond) 2008, 114:221–230.CrossRef Paterna S, Gaspare P, Fasullo S, et al.: Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond) 2008, 114:221–230.CrossRef
28.
go back to reference Oliveira RP, Velasco I, Soriano F, Friedman G: Clinical review: Hypertonic saline resuscitation in sepsis. Crit Care 2002, 6:418–423.CrossRefPubMed Oliveira RP, Velasco I, Soriano F, Friedman G: Clinical review: Hypertonic saline resuscitation in sepsis. Crit Care 2002, 6:418–423.CrossRefPubMed
29.
go back to reference Tølløfsrud S, Noddeland H: Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions. Acta Anaesthesiol Scand 1998, 42:154–161.CrossRefPubMed Tølløfsrud S, Noddeland H: Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions. Acta Anaesthesiol Scand 1998, 42:154–161.CrossRefPubMed
30.
go back to reference Tølløfsrud S, Mathru M, Kramer GC: Hypertonic–hyperoncotic solutions in open-heart surgery. Perfusion 1998, 13:289–296.PubMed Tølløfsrud S, Mathru M, Kramer GC: Hypertonic–hyperoncotic solutions in open-heart surgery. Perfusion 1998, 13:289–296.PubMed
31.
go back to reference Wildenthal K, Mierzwiak DS, Mitchell JH: Acute effects of increased serum osmolality on left ventricular performance. Am J Physiol 1969, 216:898–904.PubMed Wildenthal K, Mierzwiak DS, Mitchell JH: Acute effects of increased serum osmolality on left ventricular performance. Am J Physiol 1969, 216:898–904.PubMed
32.
go back to reference Schroth M, Plank C, Meissner U, et al.: Hypertonic–hyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics 2006, 118:e76–e84.CrossRefPubMed Schroth M, Plank C, Meissner U, et al.: Hypertonic–hyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics 2006, 118:e76–e84.CrossRefPubMed
33.
go back to reference Bueno R, Resende AC, Melo R, et al.: Effects of hypertonic saline-dextran solution in cardiac valve surgery with cardiopulmonary bypass. Ann Thorac Surg 2004, 77:604–611.CrossRefPubMed Bueno R, Resende AC, Melo R, et al.: Effects of hypertonic saline-dextran solution in cardiac valve surgery with cardiopulmonary bypass. Ann Thorac Surg 2004, 77:604–611.CrossRefPubMed
34.
go back to reference Mouren S, Delayance S, Mion G, et al.: Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated blood-perfused rabbit hearts. Anesth Analg 1995, 81:777–782.CrossRefPubMed Mouren S, Delayance S, Mion G, et al.: Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated blood-perfused rabbit hearts. Anesth Analg 1995, 81:777–782.CrossRefPubMed
35.
go back to reference Fujita T, Matsuda Y, Shibamoto T, et al.: Effect of hypertonic saline infusion on renal vascular resistance in anesthetized dogs. Jpn J Physiol 1991, 41:653–663.CrossRefPubMed Fujita T, Matsuda Y, Shibamoto T, et al.: Effect of hypertonic saline infusion on renal vascular resistance in anesthetized dogs. Jpn J Physiol 1991, 41:653–663.CrossRefPubMed
36.
go back to reference Gerber JG, Branch RA, Nies AS, et al.: Influence of hypertonic saline on canine renal blood flow and renin release. Am J Physiol 1979, 237:F441–F446.PubMed Gerber JG, Branch RA, Nies AS, et al.: Influence of hypertonic saline on canine renal blood flow and renin release. Am J Physiol 1979, 237:F441–F446.PubMed
37.
go back to reference Tucker BJ, Blantz RC: Effect of furosemide administration on glomerular and tubular dynamics in the rat. Kidney Int 1984, 26:112–121.CrossRefPubMed Tucker BJ, Blantz RC: Effect of furosemide administration on glomerular and tubular dynamics in the rat. Kidney Int 1984, 26:112–121.CrossRefPubMed
38.
go back to reference He XR, Greenberg SG, Briggs JP, Schnermann J: Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion. Hypertension 1995, 26:137–142.PubMed He XR, Greenberg SG, Briggs JP, Schnermann J: Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion. Hypertension 1995, 26:137–142.PubMed
41.
go back to reference Tuttolomondo A, Pinto A, Di Raimondo D, et al.: Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. Nutr Metab Cardiovasc Dis 2010 Mar 24 (Epub ahead of print). Tuttolomondo A, Pinto A, Di Raimondo D, et al.: Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. Nutr Metab Cardiovasc Dis 2010 Mar 24 (Epub ahead of print).
42.
go back to reference Parrinello G, Di Pasquale P, Licata G, et al.: Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail 2009, 15:864–873.CrossRefPubMed Parrinello G, Di Pasquale P, Licata G, et al.: Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail 2009, 15:864–873.CrossRefPubMed
43.
go back to reference Miettinen KH, Lassus J, Harjola VP, et al.: Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 2008, 10:396–403.CrossRefPubMed Miettinen KH, Lassus J, Harjola VP, et al.: Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 2008, 10:396–403.CrossRefPubMed
Metadata
Title
Rubbing Salt into Wounds: Hypertonic Saline to Assist with Volume Removal in Heart Failure
Authors
Mark Liszkowski
Anju Nohria
Publication date
01-09-2010
Publisher
Current Science Inc.
Published in
Current Heart Failure Reports / Issue 3/2010
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-010-0018-4

Other articles of this Issue 3/2010

Current Heart Failure Reports 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.